Home Tools
Log in
Cart

Search Result

Search Results for " cgp-57148b "

5

Compounds

Cat No. Product Name Synonyms Targets
T1621 Imatinib Mesylate ST-1571 Mesylate,STI-571,CGP-57148B Bcr-Abl , PDGFR , c-Kit , Autophagy
Imatinib Mesylate (STI-571) is a tyrosine kinase receptor inhibitor with antineoplastic activity (IC50s: 0.6 μM, 0.1 μM and 0.1 μM for v-Abl, c-Kit and PDGFR, respectively).
T11639 Imatinib D4 CGP-57148B D4,STI571 D4 Others
Imatinib D4 is a deuterium-labeled Imatinib. Imatinib is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, PDGFR, v-Abl, and c-kit kinase activity.
T11640 Imatinib-d8 CGP-57148B D8,STI571 D8 Others
Imatinib D8 is a deuterium-labeled Imatinib. Imatinib is an orally bioavailable tyrosine kinases inhibitor that inhibits BCR/ABL, PDGFR, v-Abl, and c-kit kinase activity.
T18592 Imatinib carbaldehyde CGP-57148B carbaldehyde,STI571 carbaldehyde,PROTAC ABL binding moiety 1 Others
Imatinib carbaldehyde (also known as CGP-57148B carbaldehyde) is a compound derived from Imatinib, an inhibitor of the ABL protein. Imatinib carbaldehyde binds to the IAP ligand with the assistance of a linker, resulting...
T6230 Imatinib STI571,CGP057148B,ST-1571 SARS-CoV , Bcr-Abl , PDGFR , c-Kit , Autophagy
Imatinib (STI571) is a multi-targeted receptor tyrosine kinase inhibitor that selectively inhibits the kinase activities of BCR/ABL, v-Abl, PDGFR, and c-kit with oral activity. Imatinib has antitumor activity for the tre...
TargetMol